INTRODUCTIONThe studies of the latest years highlighted how molecular biology laboratory practice changed from single to high‐throughput analysis, accompanied by an increase in the number of samples tested simultaneously.In the high‐throughput era, also the pre‐analytical phase requires the automation of the experiment setting and especially the methodology of nucleic acid extraction. Nevertheless, the current biobanking procedures and cell recovery are still labor‐intensive, requiring long time and dedicated laboratory staff.In many hematological clinical trials, as well as in the clinical practice of selected centers, bone marrow (BM) and peripheral blood (PB) samples are being collected and analyzed at diagnosis and during the treatment phases for minimal residual disease (MRD) and mutational studies. MRD analysis by polymerase chain reaction (PCR) has been shown to be a powerful early predictor of therapy response and outcome in lymphoproliferative disorders, such as acute lymphoblastic leukemia, follicular lymphoma (FL), mantle cell lymphoma (MCL), and multiple myeloma (MM).In previous published studies, MRD analysis was commonly performed on genomic DNA (gDNA) from BM or PB mononuclear cells (MNCs) collected using density gradient separation approach. Since the 80s, Ficoll, a sucrose polymer with high molecular weight (1077 g/mL), has been recommended to collect MNCs. This is a feasible procedure,
International Journal of Laboratory Hematology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera